Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: COVID-19 Antibodies  Jul 13, 2020  3 years, 9 months, 4 days, 3 hours, 46 minutes ago

BREAKTHROUGH! COVID-19 Antibodies: Researchers Identify Key Antibodies Against COVID-19 That Are Encoded By The Antibody Gene IGHV3-53

BREAKTHROUGH! COVID-19 Antibodies: Researchers Identify Key Antibodies Against COVID-19 That Are Encoded By The Antibody Gene IGHV3-53
Source: COVID-19 Antibodies  Jul 13, 2020  3 years, 9 months, 4 days, 3 hours, 46 minutes ago
COVID-19 Antibodies: A new research led Scripps Research Institute has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.


 
The researchers reviewed data on nearly 300 anti-SARS-CoV-2 antibodies that their labs and others have found in convalescent COVID-19 patients over the past few months. They noted that a subset of these antibodies is particularly powerful at neutralizing the virus, and these potent antibodies are all encoded, in part, by the same antibody gene, IGHV3-53.
 
The team used a powerful tool known as X-ray crystallography to image two of these antibodies attached to their target site on SARS-CoV-2. The resulting atomic-structure details of this interaction should be useful to vaccine designers, as well as to scientists hoping to develop antiviral drugs targeting the same site on SARS-CoV-2.
 
The research findings are published in the journal: Science https://science.sciencemag.org/content/early/2020/07/10/science.abd2321
 
Past research suggests that antibodies encoded by IGHV3-53 are generally present, at least in small numbers, in healthy people's blood. The results therefore offer hope that using a vaccine to boost levels of these ever-present antibodies will protect adequately against the virus.
 
The study's senior author Dr Ian Wilson, DPhil, Hansen Professor of Structural Biology and Chair of the Department of Integrative Structural and Computational Biology at Scripps Research told Thailand medical News, "This type of antibody has been isolated frequently in studies of COVID-19 patients, and we can now understand the structural basis for its interaction with SARS-CoV-2."
 
Co-author Dr Dennis Burton, Ph.D., professor and co-chair of the Department of Immunology and Microbiology at Scripps Research added, "This study provides important inspiration for effective COVID-19 vaccine design,"
The antibody research was a collaboration chiefly involving the Wilson and Burton labs, and the Scripps Research-based Neutralizing Antibody Center of IAVI, a prominent non-profit vaccine research organization.
 
The SARS-CoV-2 coronavirus so far has infected more than 13.2 million people around the world and killed more than 573,000, in addition to causing widespread socioeconomic disruption and damage. Developing an effective vaccine to stop the pandemic is currently the world's top public health priority.
 
Though several potential vaccines are already in clinical trials, scientists don't yet have a full understanding of the molecular features that would define a protective antibody response. In the new study, the scientists took a big step toward that goal.
 
The researchers started by analyzing 294 different SARS-CoV-2-neutralizing antibodies isolated from COVID-19 patients' blood over the past few months. Antibodies are Y-shaped proteins made in immune cells called B-cells. Each B-cell makes a specific antibody type, or clone, which is encoded by a unique combination of antibody genes in the cell. The scientists found that a n antibody gene called IGHV3-53 was the most common of the genes for the 294 antibodies, encoding about 10 percent of them.
 
The study team also noted that the IGHV3-53-encoded antibodies in their study contain an unusually short variant of the CDR H3 loop, normally a key target-binding element. These antibodies are nevertheless very potent against SARS-CoV-2 when compared to other antibodies not encoded by IGHV3-53.
 
These IGHV3-53 antibodies had yet another property suggesting that boosting their numbers would be a good and ac